Axsome Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
SHPGShire PLC Sponsored ADR
PRGOPerrigo Co. Plc
MNKMallinckrodt Plc
SAGESAGE Therapeutics, Inc.
JAZZJazz Pharmaceuticals Plc
PTLAPortola Pharmaceuticals, Inc.
UTHRUnited Therapeutics Corporation
GWPHGW Pharmaceuticals PLC Sponsored ADR
MDCOMedicines Company
ENDPEndo International Plc
ICPTIntercept Pharmaceuticals, Inc.
SUPNSupernus Pharmaceuticals, Inc.
PCRXPacira Pharmaceuticals, Inc.

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.